Fibromyalgia patients’ satisfaction with their treatment is predictable through consideration of pre-treatment, patient-specific factors, according to a study in the journal Clinical and Experimental ...

Credit: Tonix Pharmaceuticals. Tonmya is a once-daily sublingual tablet of cyclobenzaprine HCI taken at bedtime for the treatment of fibromyalgia. Clinical trials have demonstrated that Tonmya reduces ...

Tonmya is expected to be available in the fourth quarter of 2025. The Food and Drug Administration (FDA) has approved Tonmya ™ (cyclobenzaprine hydrochloride sublingual tablets) for the treatment of ...

Dear Doctors: I had muscle pain and exhaustion for two years, and no one could figure out what was wrong. A rheumatologist recently diagnosed me with fibromyalgia. I would appreciate any information ...

Many people with fibromyalgia describe the chronic condition as a "bad case of the flu that never goes away," because they have widespread pain, wake up with stiff muscles and experience brain fog, ...

Treatment with TONMYA provided statistically significant pain reduction in two Phase 3 trials and was generally well tolerated BERKELEY HEIGHTS, N.J., March 09, 2026 (GLOBE NEWSWIRE) -- Tonix ...

CHATHAM, NEW JERSEY / ACCESS Newswire / March 31, 2025 / This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding Corp. ...

PITTSBURGH--(BUSINESS WIRE)--Swing Therapeutics announced that Stanza, its digital therapeutic for treatment of fibromyalgia symptoms, has received a positive coverage decision from Highmark Health.

Dear Doctors: I had muscle pain and exhaustion for two years, and no one could figure out what was wrong. A rheumatologist recently diagnosed me with fibromyalgia. I would appreciate any information ...

Credit: Tonix Pharmaceuticals. The approval was supported by data from 3 double-blind, placebo-controlled trials that included a total of 1474 patients who met the 2016 ACR criteria for diagnosis of ...